Prosecution Insights
Last updated: August 14, 2026
Application No. 19/121,800

REMOVAL MODULE OF TISSUE REMOVAL APPARATUS

Non-Final OA §102§112
Filed
Apr 17, 2025
Priority
Oct 28, 2022 — RE 10-2022-0141485 +1 more
Examiner
GABR, MOHAMED GAMIL
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Labnpeople Co., Ltd.
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
1y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
429 granted / 532 resolved
+10.6% vs TC avg
Strong +22% interview lift
Without
With
+22.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
34 currently pending
Career history
564
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
42.2%
+2.2% vs TC avg
§102
28.0%
-12.0% vs TC avg
§112
20.5%
-19.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 532 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 6 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claim 6, the limitation “wherein an end of the snagging prevention member comes in contact with a compressing member which protrudes toward the inside of the trocar on a distal end surface of the trocar or at the distal end side of the trocar.” is indefinite because its unclear whether Applicant is attempting to positively recite the trocar as this limitation is not written as functional language. Claim 6 has yet to positively recite the trocar. The Examiner suggests amending the claims to clearly positively recite the trocar as part of the tissue removal module. Allowable Subject Matter Claim 6 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. The prior art of record fails to disclose the removal module of Claim 4, a trocar in use with the snagging prevention member, wherein an end of the snagging prevention member comes in contact with a compressing member which protrudes toward the inside of the trocar on a distal end surface of the trocar or at the distal end side of the trocar. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-5 and 7 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Cho (KR-21216702003-A) Regarding Claim 1, Cho teaches a removal module of a tissue removal apparatus, the removal module comprising: a bending portion (300; Figure 1), which is connected to a distal end of a catheter (200; Figure 1), and which is bent with a predetermined curvature by the user's manipulation at the distal end of the catheter (200; see Figure 6); and a tissue removal portion (400; Figure 1) which is exposed on the bending portion along with a shaft (420; Figure 1) that moves forward and backward by user's manipulation when the bending portion (300) is bent (Figure 6), wherein the tissue removal portion (400), when exposed to the outside at a distal end of a trocar and then inserted into the inside of the trocar, is inserted into the inside of the trocar while being deformed so as not to be snagged on a distal end side of the trocar (Figure 6). The Examiner notes that “when exposed to the outside at a distal end of a trocar and then inserted into the inside of the trocar, is inserted into the inside of the trocar while being deformed so as not to be snagged on a distal end side of the trocar” is functional language and a trocar is not yet positively recited in the claims. It is the Examiner’s position that the device of Cho can be retracted within a sheath while in the configuration of Figure 6 and thus reads on the limitation.) Regarding Claim 2, Cho teaches the removal module of Claim 1, wherein the bending portion (300) comprises: an insertion member (see Figure 5 in which insertion member is the proximal most section inserted into 200) inserted into a hole formed at the distal end of the catheter (200; Figure 5); and a bending member (310), which is integrally connected to the insertion member and is bent to a predetermined curvature (see Figures 6-7). Regarding Claim 3, Cho teaches the removal module of Claim 2, wherein the bending portion (300) is formed along the longitudinal direction of the bending member and comprises a seating groove (301; Figure 5) on which the shaft (420) passing through the distal end of the catheter (200) is seated (Figure 1 and Figure 5). Regarding Claim 4, Cho teaches the removal module of Claim 1, wherein the tissue removal portion (400) comprises: a receiving member (410), while accommodating the shaft, which is joined to a portion of a circumferential surface of the shaft (420; Figure 5); a blade, which is connected to the receiving member and which is in contact with the tissue to be removed (blades best seen in Figure 7); and a snagging prevention member (proximal most section of the blade), which is provided at a longitudinal end of the receiving member (410) and which is pre- inserted into the inside of the trocar prior to the blade (see annotated Figure 7 below) The Examiner notes that the trocar is yet to be positively recited in the claims and thus it’s the Examiner’s position that the proximal most blade can be inserted into trocar prior to a distal most blade portion. PNG media_image1.png 448 584 media_image1.png Greyscale Regarding Claim 5, Cho teaches the removal module of Claim 4, wherein an end of the snagging prevention member has a downwardly inclined shape (See annotated Figure 7 above). Regarding Claim 7, Cho teaches the removal module of Claim 4, wherein it is possible for the blade to be inserted into the inside of the trocar through an incision groove formed by an incision at the distal end side of the trocar. The Examiner notes that the trocar is yet to be positively recited in the claims and thus it’s the Examiner’s position that the blade can be inserted into trocar through an incision groove formed by the trocar, as this limitation is an intended use. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MOHAMED GAMIL GABR whose telephone number is (571)272-0569. The examiner can normally be reached M-F 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571) 270-5953. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MOHAMED G GABR/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Apr 17, 2025
Application Filed
Jul 21, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12702559
CUTTING AND BENDING TOOL FOR PELVIC IMPLANTS
3y 0m to grant Granted Aug 11, 2026
Patent 12697205
INTRAOCULAR LENS FIXATION DEVICE
3y 3m to grant Granted Aug 04, 2026
Patent 12678595
FEEDING DEVICE FOR TUBULAR COMPONENT
3y 2m to grant Granted Jul 14, 2026
Patent 12678333
EARWAX REMOVAL APPARATUS
3y 0m to grant Granted Jul 14, 2026
Patent 12678618
ANCHORING HOLDING TOOL
2y 8m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
99%
With Interview (+22.3%)
2y 10m (~1y 6m remaining)
Median Time to Grant
Low
PTA Risk
Based on 532 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month